drugset / Trial / NCT02157311
4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients
NaSingle-groupOpen-labelTreatment
Summary
Evaluate after 48 weeks, the capacity of a weekly strategy of 4 consecutive days on treatment followed by 3 days off treatment, in HIV-1 treated patients with undetectable viral load for at least 12 months and continuous antiretroviral regimen unchanged for at least 4 months, to maintain a therapeutic success defined by the absence of virological failure (2 consecutive viral loads \> 50 cp/mL) and the absence of interruption of therapeutic strategy (interruption or change of the " 4 days on / 3 days off " strategy for a time longer than 30 consecutive days).
Timeline
- Start
- 2014-07
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Abacavir | Other / unclassified | — | — |
| Background | Atazanavir | Other / unclassified | — | — |
| Background | Darunavir | Small molecule | — | — |
| Background | Efavirenz | Other / unclassified | — | — |
| Background | Etravirine | Small molecule | — | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Lopinavir | Other / unclassified | — | — |
| Background | Rilpivirine | Small molecule | — | — |
| Background | Tenofovir | Small molecule | — | — |
| Background | emtricitabine | Other / unclassified | — | — |